Home > Annual Financials > REMEDIUM LIFECARE

REMEDIUM LIFECARE Financial Statement Analysis
[BOM: 539561]

The Revenues of REMEDIUM LIFECARE have increased by 1.00% YoY .
The Earnings Per Share (EPS) of REMEDIUM LIFECARE has increased by 404.01 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

REMEDIUM LIFECARE Last 5 Annual Financial Results
[BOM: 539561]

StandaloneMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹510 Cr₹505 Cr₹90 Cr₹2.89 Cr₹0.16 Cr
Expenses ₹503 Cr₹503 Cr₹89 Cr₹2.50 Cr₹0.23 Cr
Operating Profit (Excl OI) ₹7.17 Cr₹1.82 Cr₹0.72 Cr₹0.39 Cr₹-0.07 Cr
Other Income ₹0.83 Cr₹0.01 Cr₹0.01 Cr₹0.01 Cr₹0.09 Cr
Interest ₹0.45 Cr₹0.23 Cr₹0.02 Cr₹0.01 Cr₹0.00 Cr
Depreciation ₹0.15 Cr₹0.07 Cr₹0.06 Cr₹0.01 Cr₹0.00 Cr
Profit Before Tax ₹7.40 Cr₹1.53 Cr₹0.65 Cr₹0.38 Cr₹0.02 Cr
Profit After Tax ₹5.43 Cr₹1.08 Cr₹0.48 Cr₹0.28 Cr₹0.01 Cr
Consolidated Net Profit ₹5.43 Cr₹1.08 Cr₹0.48 Cr₹0.28 Cr₹0.01 Cr
Earnings Per Share (Rs)₹15.07₹2.99₹1.33₹0.77₹0.02
PAT Margin (%)1.060.210.539.585.03
ROE(%)70.9224.5113.338.620.26
ROCE(%)102.5418.167.3911.160.62
Total Debt/Equity(x)0.000.002.720.110.02

Key Financials

Market Cap : ₹ 812.4 Cr
Revenue (TTM) : ₹ 2,708.8 Cr
Net Profit(TTM) : ₹ 75.8 Cr
EPS (TTM) : ₹ 7.5
P/E (TTM) : 10.7

Industry Peers & Returns1W1M1Y
REMEDIUM LIFECARE -18.5% -32% 13.7%
ADANI ENTERPRISES 1.6% -9.9% 47.7%
REDINGTON 1.1% -4.9% 22.4%
HONASA CONSUMER -0.4% 6.3% NA
MMTC -2.1% -8.4% 126.7%
MSTC -1.8% -11.1% 165.9%
LLOYDS ENTERPRISES -4.8% -2% 299.8%
VERITAS (INDIA) -7.8% 7.4% 841.2%
NOVARTIS INDIA -2.1% 0.1% 70.7%


REMEDIUM LIFECARE Revenues
[BOM: 539561]

Y-o-Y

1.00 %

5 Yr CAGR

652.50 %

Years Revenues % Change
Mar2023 ₹510 Cr
1.00
Mar2022 ₹505 Cr
460.67
Mar2021 ₹90 Cr
3,015.36
Mar2020 ₹2.89 Cr
1,717.61
Mar2019 ₹0.16 Cr -


REMEDIUM LIFECARE Operating Profit
[BOM: 539561]

Y-o-Y

294.99 %

5 Yr CAGR

Positive

Years Operating Profit % Change
Mar2023 ₹7.17 Cr
294.99
Mar2022 ₹1.82 Cr
151.04
Mar2021 ₹0.72 Cr
86.34
Mar2020 ₹0.39 Cr
Positive
Mar2019 ₹-0.07 Cr -

Operating Margins
Y-o-Y

291.67 %

5 Yr CAGR

Positive

Years Operating Margin% % Change
Mar2023 1.41%
291.67
Mar2022 0.36%
-55.00
Mar2021 0.8%
-94.04
Mar2020 13.43%
Positive
Mar2019 -43.4% -

REMEDIUM LIFECARE Profit After Tax
[BOM: 539561]

Y-o-Y

403.34 %

5 Yr CAGR

410.33 %

Years Profit After Tax % Change
Mar2023 ₹5.43 Cr
403.34
Mar2022 ₹1.08 Cr
124.12
Mar2021 ₹0.48 Cr
73.65
Mar2020 ₹0.28 Cr
3,362.50
Mar2019 ₹0.01 Cr -

PAT Margins
Y-o-Y

404.76 %

5 Yr CAGR

-32.25 %

Years PAT Margin(%) % Change
Mar2023 1.06 %
404.76
Mar2022 0.21 %
-60.38
Mar2021 0.53 %
-94.47
Mar2020 9.58 %
90.46
Mar2019 5.03 % -

REMEDIUM LIFECARE Earnings Per Share (EPS)
[BOM: 539561]

Y-o-Y

404.01 %

5 Yr CAGR

423.93 %

Years EPS % Change
Mar2023 ₹15
404.01
Mar2022 ₹2.99
124.81
Mar2021 ₹1.33
72.73
Mar2020 ₹0.77
3,750.00
Mar2019 ₹0.02 -

REMEDIUM LIFECARE Return on Capital Employed (ROCE)
[BOM: 539561]

Y-o-Y

464.65 %

5 Yr CAGR

258.61 %

Years ROCE % Change
Mar2023 102.54%
464.65
Mar2022 18.16%
145.74
Mar2021 7.39%
-33.78
Mar2020 11.16%
1,700.00
Mar2019 0.62% -

REMEDIUM LIFECARE Share Price vs Sensex

Current Share Price : ₹80.6
Current MarketCap: ₹ 812.4 Cr
Updated EOD on :May 14,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
REMEDIUM LIFECARE

-18.5%

-32%

13.7%

SENSEX

-0.6%

-2.1%

18.4%

REMEDIUM LIFECARE related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about REMEDIUM LIFECARE Financials


How the annual revenues of REMEDIUM LIFECARE have changed ?

The Revenues of REMEDIUM LIFECARE have increased by 1.00% YoY .

How the Earnings per Share (EPS) of REMEDIUM LIFECARE have changed?

The Earnings Per Share (EPS) of REMEDIUM LIFECARE has increased by 404.01 % YoY .